Neuland Laboratories Ltd
company logo

Neuland Laboratories Ltd

Pharmaceuticals
Mid Cap

-

- (0%)


Neuland Laboratories Ltd Performance

-

-

-

-


-

-

-

-

-

Neuland Laboratories Ltd Fundamentals

10,385.54Cr

34.58

8.10

0.10

234.12

0.17%

999.07

i buttonClick here to know more about Fundamentals

Neuland Laboratories Ltd Financials

Neuland Laboratories Ltd Financialsright-arrow

Neuland Laboratories Ltd Shareholding Pattern

Neuland Laboratories Ltd Delivery and Volume

About Neuland Laboratories Ltd

Set up in 1984 as a private limited company to manufacture bulk drugs, Neuland Laboratories (NLL) is promoted by Davuluri Sucheth Rao. Neuland Drugs & Pharmaceuticals Pvt Ltd, a company set up by the same promoters to manufacture bulk drugs was merged with NLL with effect from Apr.'92. NLL manufactu

-

1984

NEULANDLAB

NameDesignation
D R RaoExecutive Chairman
Christopher M CimarustiNon Executive Director
D Sucheth RaoVice Chairman & CEO
D Saharsh RaoVice Chairman & M.D.
Sarada BhamidipatiCompany Sec. & Compli. Officer
Nirmala MurthyIndependent Director
Homi Rustam KhusrokhanIndependent Director
Prasad R MenonIndependent Director
Sugata SircarIndependent Director
Pallavi Joshi BakhruIndependent Director
News and Events...

Similar Stocks

What's Trending

Neuland Laboratories Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Neuland Laboratories Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Neuland Laboratories Ltd's share price is ₹8078.3 as of 2024-07-13.
Neuland Laboratories Ltd's P/E ratio is 34.58 times as of 2024-07-13.
Neuland Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 8.1, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Neuland Laboratories Ltd's market capitalization is ₹10385.54 Cr as on 2024-07-13.
The current financial records of Neuland Laboratories Ltd show a 26.48% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Neuland Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹932.18, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Neuland Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Neuland Laboratories Ltd's 52-week high and low as of 2024-07-13 are ₹8152.75 and ₹8018.05, respectively.